MedElevator
Войти в исследования Clinical journal of the American Society of Nephrology : CJASN · 2026
Long-Term Exposure to Fine Particulate Matter and Kidney Function among Patients with Polycystic Kidney Disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kwag Youngrin, Min Jieun, Lee Whanhee, Ahn Seoyeong, Kim Sooyoung, Ha Hyojin, Kim Min-Ho, Oh Jongmin, Kang Duk-Hee, Ha Eunhee
Аннотация
KEY POINTS: Long-term exposure to fine particulate matter was associated with faster decline in kidney function among patients with polycystic kidney disease. Associations were stronger in younger patients and those with preserved kidney function at baseline. The association was weaker among patients prescribed tolvaptan.
BACKGROUND: Polycystic kidney disease (PKD) is the fourth leading cause of ESKD. Although the condition is primarily genetic, environmental exposures such as air pollution may influence disease progression.
METHODS: We investigated whether long-term exposure to fine particulate matter (PM 2 . 5 ) is associated with kidney function decline among individuals with PKD and whether this association differs by age, sex, initial kidney function, and tolvaptan use. Using the Korea National Health Information Database, we identified 18,898 adults with PKD who underwent at least two health screenings between 2016 and 2023. Annual mean PM 2 . 5 exposure was estimated with a high-resolution (1 km 2 ) machine learning-based model. Linear mixed-effects models were applied to assess the association between PM 2 . 5 exposure and changes in eGFR, adjusting for demographic, socioeconomic, and lifestyle covariates.
RESULTS: Each 1 µ g/m 3 higher lag 0-1 year PM 2 . 5 was associated with a -0.09 ml/min per 1.73 m 2 change in eGFR (95% confidence interval [CI], -0.16 to -0.01). More evident associations were observed among younger adults (-0.26; 95% CI, -0.42 to -0.09), individuals with preserved baseline kidney function (-0.14; 95% CI, -0.21 to -0.07), male (-0.10; 95% CI, -0.21 to 0), and individuals who were not prescribed tolvaptan (-0.12; 95% CI, -0.20 to -0.04).
CONCLUSIONS: Chronic exposure to PM 2 . 5 appears to be an environmental modifier of kidney function decline in PKD, particularly among younger individuals and those with preserved kidney function. Environmental risk reduction strategies, together with pharmacologic therapy, may help delay the onset of ESKD in this vulnerable population.
BACKGROUND: Polycystic kidney disease (PKD) is the fourth leading cause of ESKD. Although the condition is primarily genetic, environmental exposures such as air pollution may influence disease progression.
METHODS: We investigated whether long-term exposure to fine particulate matter (PM 2 . 5 ) is associated with kidney function decline among individuals with PKD and whether this association differs by age, sex, initial kidney function, and tolvaptan use. Using the Korea National Health Information Database, we identified 18,898 adults with PKD who underwent at least two health screenings between 2016 and 2023. Annual mean PM 2 . 5 exposure was estimated with a high-resolution (1 km 2 ) machine learning-based model. Linear mixed-effects models were applied to assess the association between PM 2 . 5 exposure and changes in eGFR, adjusting for demographic, socioeconomic, and lifestyle covariates.
RESULTS: Each 1 µ g/m 3 higher lag 0-1 year PM 2 . 5 was associated with a -0.09 ml/min per 1.73 m 2 change in eGFR (95% confidence interval [CI], -0.16 to -0.01). More evident associations were observed among younger adults (-0.26; 95% CI, -0.42 to -0.09), individuals with preserved baseline kidney function (-0.14; 95% CI, -0.21 to -0.07), male (-0.10; 95% CI, -0.21 to 0), and individuals who were not prescribed tolvaptan (-0.12; 95% CI, -0.20 to -0.04).
CONCLUSIONS: Chronic exposure to PM 2 . 5 appears to be an environmental modifier of kidney function decline in PKD, particularly among younger individuals and those with preserved kidney function. Environmental risk reduction strategies, together with pharmacologic therapy, may help delay the onset of ESKD in this vulnerable population.